Seaport Therapeutics, Inc.
SPTX$901M
Small CapNASDAQBiotechnology🇺🇸North America58 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Mar 15, 2027
42wMarket Overview
Stock performance and key metrics
SPTX News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
SPT-300 | Phase 2 | Major Depressive Disorder (MDD) | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply